ABYXXIO Trademark

Trademark Overview

On Monday, October 5, 2020, a trademark application was filed for ABYXXIO with the United States Patent and Trademark Office. The USPTO has given the ABYXXIO trademark a serial number of 90236272. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 2, 2024. This trademark is owned by ADC Therapeutics SA. The ABYXXIO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology
abyxxio

General Information

Serial Number90236272
Word MarkABYXXIO
Filing DateMonday, October 5, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 31, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 19, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameADC Therapeutics SA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressEpalinges 1066
CH
Party NameADC Therapeutics SA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressEpalinges 1066
CH

Trademark Events

Event DateEvent Description
Thursday, October 8, 2020NEW APPLICATION ENTERED
Thursday, November 19, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 2, 2021ASSIGNED TO EXAMINER
Wednesday, February 3, 2021NON-FINAL ACTION WRITTEN
Wednesday, February 3, 2021NON-FINAL ACTION E-MAILED
Wednesday, February 3, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 20, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 20, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 21, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 26, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 11, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 31, 2021PUBLISHED FOR OPPOSITION
Tuesday, August 31, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 26, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, April 18, 2022SOU TEAS EXTENSION RECEIVED
Monday, April 18, 2022SOU EXTENSION 1 FILED
Monday, April 18, 2022SOU EXTENSION 1 GRANTED
Wednesday, April 20, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 4, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, October 4, 2022SOU EXTENSION 2 FILED
Tuesday, October 4, 2022SOU EXTENSION 2 GRANTED
Thursday, October 6, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 22, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, March 22, 2023SOU EXTENSION 3 FILED
Wednesday, March 22, 2023SOU EXTENSION 3 GRANTED
Friday, March 24, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 23, 2023SOU TEAS EXTENSION RECEIVED
Monday, October 23, 2023SOU EXTENSION 4 FILED
Monday, October 23, 2023SOU EXTENSION 4 GRANTED
Wednesday, October 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 18, 2024SOU TEAS EXTENSION RECEIVED
Thursday, April 18, 2024SOU EXTENSION 5 FILED
Thursday, April 18, 2024SOU EXTENSION 5 GRANTED
Friday, April 19, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 2, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, December 2, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

abyxxio pharmaceutical preparations oncology treatment cancer